B M Chen Selected Research

hydroxyaniline mustard

12/2001	Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy.
3/2000	Efficient clearance of poly(ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B M Chen Research Topics

Disease

3	Neoplasms (Cancer) 12/2001 - 03/2000
2	Infections 05/2022 - 08/2001
1	Eructation (Eructations) 05/2022
1	Spontaneous Abortion (Miscarriage) 11/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Ascites 12/2001
1	Hepatocellular Carcinoma (Hepatoma) 12/2001
1	Carcinoma (Carcinomatosis) 11/2000
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2000

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 12/2001 - 03/2000
2	ProdrugsIBA 12/2001 - 03/2000
2	hydroxyaniline mustardIBA 12/2001 - 03/2000
2	GlucuronidesIBA 12/2001 - 03/2000
1	Cetuximab (Erbitux)FDA Link 01/2017
1	GlucuronidaseIBA 12/2001
1	EndotoxinsIBA 08/2001
1	Thromboplastin (Tissue Factor)IBA 08/2001
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2000
1	trioctyl phosphine oxide (TOPO)IBA 11/2000
1	CamptothecinIBA 11/2000
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 11/2000
1	Superhelical DNA (Supercoiled DNA)IBA 11/2000
1	Pharmaceutical PreparationsIBA 11/2000
1	Ethylene Glycol (Monoethylene Glycol)IBA 03/2000
1	Immunoglobulin M (IgM)IBA 03/2000

Therapy/Procedure

3	Therapeutics 05/2022 - 03/2000
2	Drug Therapy (Chemotherapy) 01/2017 - 03/2000
1	Cardiopulmonary Resuscitation (CPR) 11/2018
1	Transplantation 12/2001
1	Intravenous Administration 03/2000